Table 4.
Risk level | Risk due to nature or risks caused by nature of treatment of malignancy |
---|---|
High | Alkylating agents: cyclophosphamide, ifosfamide, chlormethine, busulfan, melphalan, chlorambucil, carmustine, lomustine, mechlorethamine; procarbazide |
Medium | Cisplatin, carboplatin, doxorubicin |
Low <20 % | Vincristine, methotrexate, dactinomycin, bleomycin, mercaptopurine, vinca alkaloids (vinblastine), fluorouracil |
Risk exists unknown level | Nitrosources & antimetabolites: cytosine arabinoside |
Unknown risk | Taxanes, oxaliplatin, monoclonal antibodies (trastuzumab, bevacizumab, cetuximab), tyrosine kinase inhibitors (eriotinib, imatinib) |
Taken with kind permission from Ronit Abir
Cancer in Female Adolescents [31]. Elad Feigin, Ronit Abir, Fertility Preservation in Female Adolescents with Malignancies
© 2008 Nova Science Publishers, Inc